Q-Linea
0.038
SEK
0 %
Less than 1K followers
QLINEA
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Ownership
Investor consensus
0%
-12.64%
-90.16%
-61.08%
-88.92%
-91.85%
-99.74%
-99.57%
-99.6%
Q-Linea operates in the medical technology sector. The company specializes in research and development of instruments and consumables. The products are mainly used in the treatment of infectious diseases and blood poisoning, and include diagnostic and analytical tools, as well as basic sample handling. The technology is based on the so-called ID and AST technology. Q-Linea was founded in 2008 and is headquartered in Uppsala.
Read moreMarket cap
169.03M SEK
Turnover
353.66K SEK
Revenue
2.36M
EBIT %
-9,052.54 %
P/E
-
Dividend yield-%
-
Financial calendar
26.6
2025
General meeting '25
10.7
2025
Interim report Q2'25
30.10
2025
Interim report Q3'25
All
Webcasts
Press releases
ShowingAll content types
Q-linea publish the Annual report for 2024
Q-linea announces strong support of the TO1 warrant program as well as an extension of existing loan from large shareholder
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Redeye: Q-linea - Improved commercial momentum
